Daratumumab-induced transient myopic shift
Purpose: To describe an unprecedented case of transient myopic shift induced by a chemotherapeutic agent, daratumumab. Observations: A 43-year-old emmetropic female with multiple myeloma experienced sudden onset of myopic shift during her first intravenous dose of daratumumab, an increasingly common...
Main Authors: | Maria A. Mavrommatis, Hoon Jung, Ajai Chari, Bart Barlogie, James G. Chelnis |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-03-01
|
Series: | American Journal of Ophthalmology Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451993618301750 |
Similar Items
-
Cefixime-induced angle closure and transient myopic shift in a healthy individual; A case report
by: Reza Mirshahi, et al.
Published: (2020-12-01) -
Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma
by: Larysa Sanchez, et al.
Published: (2021-01-01) -
Topiramate-induced Myopic Shift and Bilateral Secondary Angle-closure Glaucoma
by: Özgür Örüm, et al.
Published: (2012-03-01) -
689 Pharmacodynamic results with talquetamab and daratumumab in patients with relapsed/refractory multiple myeloma in TRIMM-2
by: Lien Vandenberk, et al.
Published: (2023-11-01) -
Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma Patients
by: Kristine A. Frerichs, et al.
Published: (2021-05-01)